Investors / Benchstrength
Benchstrength
Benchstrength is a venture capital firm based in the United States. Benchstrength has backed 1 Canadian AI company in the Index, joining 2 tracked rounds and leading 1. The most recent was Altis Labs's US$25M Series A in September 2026. Benchstrength most often invests alongside Debiopharm Innovation Fund, Fusion Fund and Innovation Endeavors.
VC based in US. 1 Canadian AI company in the Index, 2 tracked rounds, 1 as lead.
- Type
- VC
- HQ country
- US
- Companies
- 1
- Tracked rounds
- 2
- Led
- 1
- First tracked deal
- Altis Labs, Jun 2023
- Latest tracked deal
- Altis Labs, Sep 2026
Portfolio
| Company | Rounds joined (date, round size) | Company's total raised | Role |
|---|---|---|---|
| Altis Labs | Seed · Jun 2023 · US$6M round (lead)Series A · Sep 2026 · US$25M round | US$31M | Led Seed |
A round's size is the whole round as announced, not this investor's cheque.
Frequent co-investors
Debiopharm Innovation Fund (1 shared round), Fusion Fund (1 shared round), Innovation Endeavors (1 shared round), Lumira Ventures (1 shared round), OrbiMed (1 shared round), Qiming Venture Partners USA (1 shared round)
Data as of November 10, 2026.